Anti-Inflammatories Flashcards
3 inflammatory cytokines
TNF-alpha
IL-1
IL-6
DMARDs
Disease modifying antirheumatic drugs
Infliximab
Humanized Anti TNF-alpa antibody
Long half-life
Increased risk of infection
Infliximab uses
RA
Crohn’s
Adalimumab
Human Anti TNF-alpha Antibody
Etanercept
Fusion protein–> anti TNF-alpha
Anakinra
Competetive IL-1 receptor antagonist
Short half-life
increase infection risk
Anakinra uses
RA
other inflammatory diseases
3 actions of JAK signalling pathways
IL-6 inflammation
IL-2, 4, 17 adaptive immunity
Bone marrow development
Tofacitinib
JAK inhibitor
Myelosuppression, Anemia, Infection
Primary treatment for RA
First follow-up if failing
Methotrexate (DHFR inhibitor)
Tofacitinib (Jak kinase inhibitor)
Lipid metabolites
Inflammation mediators
Dual action of glucocorticosteroids
Anti-inflammatory
Immunosuppressant
Anti-inflammatory MOA of Prednisone (glucocorticosteroids)
Decrease expression of the 3 C’s:
–>cytokines, chemokines, COX-2
Increased expression of Annexins (inhibit PLA2)
PLA2
Activated by antigen–> releases arachidonic acid from membrane for production of PROSTAGLANDINS and LEUKOTRIENES